# Use of Immunosuppressive Therapy for Sarcoidosis

> **NCT02356445** · — · UNKNOWN · sponsor: **University of Cincinnati** · enrollment: 2000 (estimated)

## Conditions studied

- Sarcoidosis

## Interventions

- **OTHER:** Cytotoxic drug

## Key facts

- **NCT ID:** NCT02356445
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2018-11
- **Final completion:** 2018-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2017-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02356445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02356445, "Use of Immunosuppressive Therapy for Sarcoidosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02356445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*